The medication bimatoprost — marketed under the brand name Latisse — is approved by the Food and Drug Administration (FDA) to treat inadequate eyelashes (hypotrichosis). Bimatoprost is also marketed under the brand name Lumigan, which is used in prescription eyedrops to treat glaucoma.
What really helps your eyelashes grow?
The way your eyelashes look is most likely genetic or because you already have thin hair. Lashes may get damaged over time, so you can condition them with moisturizers like coconut oil or castor oil to help them appear thicker and fuller. Latisse is the only FDA-approved product that makes eyelashes grow longer.
What is in Latisse that makes lashes grow?
Bimatoprost makes the eyelashes more noticeable by causing more eyelashes to grow and making them longer, thicker, and darker. Bimatoprost is similar to a natural chemical in the body (prostaglandin). Bimatoprost is also used to treat glaucoma.
Do you need prescription for Latisse?
Amir Moradi, Plastic Surgeon: LATISSE® is a prescription medication to grow the eyelashes longer, fuller and darker, indicated for people with inadequate or not enough lashes. LATISSE® needs to be prescribed by a doctor to assure the proper treatment and use.
Is there anything better than Latisse?
In general, Revitalash is less expensive than Latisse. … “Ultimately, it comes down to personal preference.” Some people feel more comfortable purchasing Revitalash because it has less chance of producing side effects, while some prefer to start with a more potent product.
Why Latisse is bad for you?
Potential side effects of Latisse include: Redness of the thin tissue over the white part of the eye (conjunctiva) Itchy, red eyes. Dry eyes.
How much does Latisse cost at CVS?
Average 12 Month Prices for Latisse (Brand) & Bimatoprost (Generic)
|Pharmacy||Latisse Retail Price||Bimatoprost Retail Price|
Is there a generic version of Latisse?
Sandoz launches generic version of Latisse® Princeton, December 7, 2016 – Sandoz today announced the US market introduction of bimatoprost ophthalmic solution, 0.03% (0.3 mg/mL), which is a generic version of Allergan’s Latisse.